What happened According to a Securities and Exchange Commission (SEC) filing dated February 17, 2026, OLD MISSION CAPITAL LLC increased its stake in iShares MSCI China ETF (NASDAQ:MCHI)by 741,450 shares during the fourth quarter. The quarter-end value of the position increased by $41.10 million, which includes both new purchases and market price changes. What else to know This was a buy transaction. The MCHI stake represents 1.84% of the fund’s $4.37 billion reportable AUM post trade. Top holdings afte ...

Aside from a brief sell-off in spring 2025, the tech sector went on a virtually uninterrupted run in the three-year period from 2023 to the end of 2025 -- gaining 131%. Here's why the tech sector is under pressure in 2026, why pockets of the sector are doing very well while others are doing poorly, and a low-cost exchange-traded fund (ETF) that could be worth a closer look. Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensa ...

Apollo Global Management Inc. has netted roughly $250 million in paper gains so far from a bet it made in recent months to support Elon Musk’s xAI. The gains came as part of an investment Apollo made that will give the artificial-intelligence startup access to Nvidia Corp.’s graphics processing units, according to people familiar with the matter. Apollo has invested $7 billion in xAI debt, the people said, asking not to be identified discussing confidential information. Most Read from Bloomberg Represe ...

Let's bring in Dan Res Muen. He's the founder and portfolio manager at Verdad Capital. Dan, really appreciate it.And it's important to set the stage here because in some ways there were going to be problems or or the sort of problems were going to come home to roost in private equity one way or the other. And we thought it was going to be from higher interest rates. you know that that in many ways was going to be the no one really saw oh by the way the thing they invested in private equity and credit over t ...

Core Viewpoint - Eos Energy Enterprises, Inc. is under investigation for potential violations of federal securities laws due to misleading statements regarding its revenue growth and manufacturing efforts [1][3]. Group 1: Investigation Details - The investigation focuses on whether Eos made false and misleading statements to investors about its near-term revenue growth and the execution of its manufacturing initiatives [3][9]. - Eos manufactures zinc-based long-duration battery energy storage systems aimed at supporting renewable energy and grid reliability [2]. Group 2: Financial Performance - Eos reported a significant net loss of approximately $970 million for fiscal year 2025, which was attributed to high spending on scaling manufacturing operations and inefficiencies [4]. - The company disclosed that its full-year 2025 revenue fell short of previously reaffirmed guidance, and it issued weaker-than-expected revenue guidance for 2026 due to slower production progress [4]. Group 3: Stock Market Reaction - Following the announcement of its financial results and guidance, Eos's stock price dropped over 39% on February 26, 2026 [5][9].

DJT Eyes Truth Social Spinoff as Trumps Lean into Fusion Fantasy - Moby BREAKING NEWS The President’s eponymous social media company, Trump Media & Technology Group (DJT), fell nearly 2.5% Friday after it announced it plans to spinoff Truth Social, the far-right social media site and the company’s only notable asset The separation looks less like a strategic pivot and more like DJT setting up Truth Social for a reverse merger it likely can’t execute on its own via a SPAC, Texas Ventures Acquisition III. ...

Core Viewpoint - Telo Genomics Corp. has increased its non-brokered private placement of secured convertible debentures from $1,200,000 to $1,600,000 to support its diagnostic and prognostic test development for human diseases [1] Group 1: Offering Details - The Debentures will have a 15% annual interest rate, compounded quarterly, and will mature on December 15, 2026 [2] - Holders can convert the principal amount of the Debentures into common shares at a conversion price of $0.05 per share before the Maturity Date [2] - For every $100,000 of Debentures issued, the company will issue 2 million Detachable Warrants, each exercisable at $0.08 per share for 12 months [2] Group 2: Financial Proceeds - The company previously closed an initial tranche of the offering, raising $840,000 by issuing Debentures and 16,800,000 Warrants [3] - The company plans to close one or two additional tranches for up to $760,000, with the final tranche expected by March 6, 2026 [3] - Net proceeds from the Upsized Offering will be allocated for working capital and general corporate purposes [4] Group 3: Regulatory and Compliance - All securities issued will be subject to a statutory hold period of four months and one day from the issuance date, in line with Canadian securities laws [4] - The Upsized Offering is contingent upon receiving necessary regulatory approvals, including from the TSX Venture Exchange [4] Group 4: Company Overview - Telo Genomics is a biotech company focused on developing diagnostic solutions through telomere analysis, with applications in oncology and neurological diseases [6] - The company’s technology has been validated in over 160 peer-reviewed publications and 30 clinical studies involving more than 3,000 patients [6] - The lead application, Telo-MM, aims to provide actionable information for treating Multiple Myeloma, a serious blood cancer [6]

The dollar index (DXY00) on Friday fell by -0.21%.  The dollar moved lower on Friday as a decline in the 10-year T-note yield to a 4-month low has weakened the dollar's interest rate differentials.  Losses in the dollar were limited on Friday due to stronger-than-expected US economic reports on Jan PPI, the Feb MNI Chicago PMI, and Dec construction spending.  Also, Friday's equity market slump boosted liquidity demand for the dollar. US Jan PPI final demand rose +0.5% m/m and +2.9% y/y, stronger than exp ...

JPMorgan Chase & Co. (NYSE:JPM) CEO Jamie Dimon warned that artificial intelligence (AI) could significantly disrupt jobs and urged policymakers and companies to plan for workforce changes before large-scale displacement occurs. AI Deployment, Job Disruption Concerns On Tuesday, speaking at a company event, Dimon said businesses and governments should proactively prepare for potential job losses driven by AI, reported Fortune. He stressed that the issue should be addressed "now" rather than after disrupti ...

Core Insights - Teledyne Marine and M Subs have signed a Memorandum of Understanding (MOU) to establish a strategic collaboration [1] - The partnership aims to leverage the complementary expertise of both organizations [1] - The focus of this collaboration is to develop and execute business opportunities related to the UK Royal Navy [1]